title: Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization.
abstract: Behavioral sensitization has been widely studied in animal models and is theorized to reflect neural modifications associated with human psychostimulant addiction. While the mesolimbic dopaminergic pathway is known to play a role, the neurochemical mechanisms underlying behavioral sensitization remain incompletely understood. In this study, we conducted the first metabolomics analysis to globally characterize neurochemical differences associated with behavioral sensitization. Methamphetamine (MA)-induced sensitization measures were generated by statistically modeling longitudinal activity data for eight inbred strains of mice. Subsequent to behavioral testing, nontargeted liquid and gas chromatography-mass spectrometry profiling was performed on 48 brain samples, yielding 301 metabolite levels per sample after quality control. Association testing between metabolite levels and three primary dimensions of behavioral sensitization (total distance, stereotypy and margin time) showed four robust, significant associations at a stringent metabolome-wide significance threshold (false discovery rate, FDR <0.05). Results implicated homocarnosine, a dipeptide of GABA and histidine, in total distance sensitization, GABA metabolite 4-guanidinobutanoate and pantothenate in stereotypy sensitization, and myo-inositol in margin time sensitization. Secondary analyses indicated that these associations were independent of concurrent MA levels and, with the exception of the myo-inositol association, suggest a mechanism whereby strain-based genetic variation produces specific baseline neurochemical differences that substantially influence the magnitude of MA-induced sensitization. These findings demonstrate the utility of mouse metabolomics for identifying novel biomarkers, and developing more comprehensive neurochemical models, of psychostimulant sensitization.
authors.affiliation: Center for Biomarker Research and Personalized Medicine.
authors.forename: D E
authors.initials: DE
authors.lastname: Adkins
authors.forename: J L
authors.initials: JL
authors.lastname: McClay
authors.forename: S A
authors.initials: SA
authors.lastname: Vunck
authors.forename: A M
authors.initials: AM
authors.lastname: Batman
authors.forename: R E
authors.initials: RE
authors.lastname: Vann
authors.forename: S L
authors.initials: SL
authors.lastname: Clark
authors.forename: R P
authors.initials: RP
authors.lastname: Souza
authors.forename: J J
authors.initials: JJ
authors.lastname: Crowley
authors.forename: P F
authors.initials: PF
authors.lastname: Sullivan
authors.forename: E J C G
authors.initials: EJ
authors.lastname: van den Oord
authors.forename: P M
authors.initials: PM
authors.lastname: Beardsley
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D002087:Butyrates / Q000378:metabolism; D002336:Carnosine / Q000031:analogs & derivatives / Q000378:metabolism; D059333:Central Nervous System Sensitization; D006146:Guanidines / Q000378:metabolism; D007294:Inositol / Q000378:metabolism; D008297:Male; D055442:Metabolome; D008694:Methamphetamine / Q000493:pharmacokinetics* / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D010205:Pantothenic Acid / Q000378:metabolism
chemical_list: C508110:4-guanidinobutyrate; D002087:Butyrates; D006146:Guanidines; D010205:Pantothenic Acid; C005038:homocarnosine; D008694:Methamphetamine; D007294:Inositol; D002336:Carnosine
keywords: Addiction; homocarnosine; metabolomics; myo-inositol; sensitization; stimulant
references.citation: Synapse. 1995 Feb;19(2):77-87
references.pmid: 7725245
references.citation: Neuropharmacology. 2002 Jun;42(7):976-86
references.pmid: 12069908
references.citation: Biometrics. 2000 Jun;56(2):645-6
references.pmid: 10877330
references.citation: Hum Psychopharmacol. 2005 Jul;20(5):309-26
references.pmid: 15880397
references.citation: Brain Res Bull. 1994;33(4):379-85
references.pmid: 8124577
references.citation: Chem Soc Rev. 2011 Jan;40(1):387-426
references.pmid: 20717559
references.citation: Brain Res Brain Res Rev. 2003 Mar;41(2-3):203-28
references.pmid: 12663081
references.citation: Synapse. 2005 Feb;55(2):122-5
references.pmid: 15543630
references.citation: Behav Brain Res. 1994 Mar 31;61(1):59-64
references.pmid: 7913324
references.citation: Am J Psychiatry. 1999 Jun;156(6):952-4
references.pmid: 10360140
references.citation: J Neurochem. 2009 Apr;109(2):494-501
references.pmid: 19200336
references.citation: Psychopharmacology (Berl). 1976 Aug 17;48(3):271-5
references.pmid: 823582
references.citation: Exp Clin Psychopharmacol. 2011 Oct;19(5):321-41
references.pmid: 21843010
references.citation: J Neurochem. 1985 Sep;45(3):935-9
references.pmid: 2411860
references.citation: J Biol Chem. 2005 Dec 30;280(52):42508-14
references.pmid: 16239221
references.citation: Genetics. 2004 Jan;166(1):611-9
references.pmid: 15020448
references.citation: J Affect Disord. 2001 Jan;62(1-2):113-21
references.pmid: 11172878
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
references.pmid: 18640920
references.citation: Brain Res Brain Res Rev. 1997 Oct;25(2):192-216
references.pmid: 9403138
references.citation: Behav Brain Funct. 2011 Aug 01;7:29
references.pmid: 21806802
references.citation: Nat Rev Genet. 2012 Nov;13(11):807-17
references.pmid: 23044826
references.citation: Mol Psychiatry. 2004 Jul;9(7):684-97, 643
references.pmid: 15098003
references.citation: Eur J Pharmacol. 2012 Mar 15;679(1-3):75-80
references.pmid: 22306241
references.citation: Anal Chem. 2009 Aug 15;81(16):6656-67
references.pmid: 19624122
references.citation: Biochim Biophys Acta. 2006 Apr;1762(4):494-8
references.pmid: 16504488
references.citation: Nat Rev Genet. 2007 Jan;8(1):58-69
references.pmid: 17173058
references.citation: Nat Genet. 2007 Sep;39(9):1100-7
references.pmid: 17660819
references.citation: Metabolomics. 2013 Apr 1;9(2):392-402
references.pmid: 23554582
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1381-93
references.pmid: 16839653
references.citation: Epilepsia. 1999 Jul;40(7):958-64
references.pmid: 10403220
references.citation: Am J Psychiatry. 1995 Jul;152(7):1084-6
references.pmid: 7793450
references.citation: Neuroscientist. 2002 Dec;8(6):562-73
references.pmid: 12467378
references.citation: J Neurosci. 1992 Oct;12(10):3773-80
references.pmid: 1357114
references.citation: Nat Rev Neurosci. 2001 Feb;2(2):119-28
references.pmid: 11252991
references.citation: Toxicol Pathol. 2009 Jun;37(4):521-35
references.pmid: 19458390
references.citation: Trends Genet. 2003 Oct;19(10):537-42
references.pmid: 14550627
references.citation: Brain. 2008 Feb;131(Pt 2):389-96
references.pmid: 18222993
references.citation: Ann Neurol. 1998 Dec;44(6):948-52
references.pmid: 9851440
references.citation: Br J Pharmacol. 1974 Feb;50(2):205-18
references.pmid: 4154116
references.citation: Synapse. 1999 Oct;34(1):11-9
references.pmid: 10459167
references.citation: J Inherit Metab Dis. 1998 Jun;21(3):268-71
references.pmid: 9686372
references.citation: Am J Psychiatry. 1997 Aug;154(8):1148-50
references.pmid: 9247405
references.citation: J Neural Transm (Vienna). 1997;104(2-3):299-305
references.pmid: 9203091
references.citation: Neuropsychopharmacology. 2009 Jan;34(1):173-86
references.pmid: 18843269
references.citation: Dev Psychopathol. 1998 Spring;10(2):395-426
references.pmid: 9635230
references.citation: J Neurosci Methods. 1994 Dec;55(2):173-82
references.pmid: 7723381
references.citation: Pharmacol Biochem Behav. 2007 May;87(1):158-63
references.pmid: 17524461
references.citation: Genes Brain Behav. 2010 Mar 1;9(2):129-59
references.pmid: 19958391
references.citation: Biol Psychiatry. 1998 Dec 1;44(11):1171-7
references.pmid: 9836021
references.citation: Ann N Y Acad Sci. 2008 Oct;1141:76-95
references.pmid: 18991952
references.citation: Genetics. 2012 Feb;190(2):389-401
references.pmid: 22345608
references.citation: Psychol Rev. 1987 Oct;94(4):469-92
references.pmid: 3317472
references.citation: Pharmacol Rev. 2011 Jun;63(2):348-65
references.pmid: 21490129
references.citation: Arch Gen Psychiatry. 2001 Jun;58(6):556-61
references.pmid: 11386984